ScPharmaceuticals (SCPH) Stock Highlights

3.39 | +2.42%

2024-12-21 06:18:57

scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The companys lead product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Statistics

Range Today

3.24 3.45

Volume Today 2.87M

Range 1 Year

3.08 6.71

Volume 1 Year 71.27M

Range 3 Year

3.08 12.75

Volume 3 Year 210.63M

Range 10 Year

2.44 18.17

Volume 10 Year 293.43M

Highlights

Market Capitalization 210.37M (small)

Floating Shares 29.45M

Current Price 3.39

Price To Earnings -2.78

Price To Revenue 8.85

Price To Book 16.43

Earnings Per Share -1.56

Payout Ratio 0%

Performance

Latest +2.42%

1 Month -3.14%

3 Months -35.8%

6 Months -14.18%

1 Year -44.24%

3 Years -28.78%

5 Years -31.4%

10 Years -76.21%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.